Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2019 Full year and fourth quarter results announcement
We will announce our 2019 full year and fourth quarter results at 12:00 GMT, 07:00 EST on Wednesday 05 February.
Following the announcement there will be a webcast, hosted by Emma Walmsley, CEO; Iain Mackay, CFO; and Hal Barron, Chief Scientific Officer and President, R&D at 14:00 GMT, 09:00 EST.
Latest information
Latest press releases
- GSK licenses tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development
- World’s first meningitis B national infant vaccination programme shows 75% drop in cases over three years
- US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma
Annual Report 2018
We published our Annual Report 2018 on 12 March 2019. View the summary and download the full report or individual sections.